"Discovery of Weak Spots in Virus Infecting 95% of Population"

The Epstein-Barr Virus (EBV), which infects around 95% of the human population and is associated with diseases like mononucleosis and certain cancers, has been found to have vulnerabilities. New research has identified weak spots on the virus's protein, gp42, and developed antibodies that could prevent infection in mice. If these findings translate to humans, it could lead to targeted treatments and potential vaccines for EBV, offering hope for preventing severe diseases caused by the virus.